Related Experiment Video
Updated: Jul 2, 2026

Protocol to Create Chronic Wounds in Diabetic Mice
Published on: September 25, 2019
Hyperhomocysteinemia and lower extremity wounds
Elissa M Schwartzfarb1, Paolo Romanelli
1Department of Dermatology and Cutaneus Surgery, University of Miami Miller School of Medicine, Miami, Florida 33136, USA.
Insights
Elevated homocysteine levels may indicate a risk for chronic lower limb wounds. This review explores homocysteine metabolism, vascular injury, and potential treatments for these debilitating conditions.
Area of Science:
- Vascular Medicine
- Metabolic Disorders
- Wound Healing Research
Background:
- Chronic lower extremity wounds, including leg and foot ulcers, stem from conditions like venous insufficiency, arterial disease, and diabetes.
- Hyperhomocysteinemia, an elevation in homocysteine levels, has been recognized for over 30 years as an independent risk factor for thrombosis, atherosclerosis, and cardiovascular disease.
Purpose of the Study:
- To review the metabolism of homocysteine.
- To examine the mechanisms of vascular injury associated with elevated homocysteine.
- To investigate the potential role of hyperhomocysteinemia as a marker for chronic lower limb ulceration and discuss treatment strategies.
Main Methods:
- Literature review focusing on homocysteine metabolism and vascular pathology.
- Analysis of existing evidence linking hyperhomocysteinemia to cardiovascular and thrombotic events.
- Exploration of studies investigating homocysteine levels in patients with chronic lower extremity wounds.
Main Results:
- Hyperhomocysteinemia is a significant risk factor for venous and arterial thrombosis and atherosclerosis.
- While a direct cause-effect relationship is not fully established, elevated homocysteine levels are suggested to be a marker for chronic lower limb ulceration.
- Understanding homocysteine metabolism and vascular injury mechanisms is crucial.
Conclusions:
- Hyperhomocysteinemia may serve as a potential biomarker for chronic lower extremity wounds.
- Further research is warranted to elucidate the precise role of homocysteine in wound pathogenesis.
- Exploring homocysteine-lowering therapies could offer new treatment avenues for patients with chronic lower limb ulceration.
Abstract:
Chronic lower extremity wounds include ulceration of the leg and foot. The underlying pathology that causes these conditions includes venous insufficiency, arterial disease, diabetes, and other less common disorders. Since the introduction of the homocysteine theory more than 30 years ago, considerable evidence has demonstrated hyperhomocysteinemia to be an independent risk factor for venous and arterial thrombosis, atherosclerosis and cardiovascular disease. Although any cause-effect relationship remains to be determined, hyperhomocysteinemia as a risk factor for these events suggests that elevated levels of homocysteine may also be a marker of chronic lower limb ulceration. This review addresses the metabolism of homocysteine, mechanisms of vascular injury, a role for hyperhomocysteinemia in lower extremity wounds and possible means of treatment.
Related Concept Videos
Diabetic Foot Ulcer
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Healing II: Complications
Venous Thrombosis I: Introduction
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis IV: Nursing Management